Floatz logo

L-Ornithine L-Aspartate

Hepatic Encephalopathy

Jinnah Postgraduate Medical CentrePhase 4 / ApprovedActive
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
71/ 100
Competitive Position
81/ 100

Competitive context

22 Active assets in the Hepatic Encephalopathy cohort.

Asset / SponsorPhaseRating
Rifaximin
General Hospital of Shenyang Military Region
Phase 4BBB
LACTULOSE
General Hospital of Shenyang Military Region
Phase 4BBB
NORMAL HUMAN SERUM ALBUMIN
General Hospital of Shenyang Military Region
Phase 4BB
L-Ornithine-L-Aspartate
Qurratul Ain Jamil
Phase 4BB
ORNITHINE
Imperial College London
Phase 4BB

View all 47 →

Same molecule, other indications

L-Ornithine L-Aspartate is also rated in:

cirrhosis of liverDormant
BB
Indicative ·
65 / 100
View asset →
breast cancerDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →